> ## Content Index
> Fetch the complete content index at: https://psychedelicmentalhealth.net/llms.txt
> Use this file to discover other available public pages before exploring further.

# Spotlight: Single Treatment With MM120 (Lysergide) in Generalized Anxiety DisorderA Randomized Clinical Trial (Robinson, et al, 2025)
- URL: https://psychedelicmentalhealth.net/spotlight-single-treatment-with-mm120-lysergide-in-generalized-anxiety-disordera-randomized-clinical-trial-robinson-et-al-2025/
- Published: 2025-09-04T15:37:52.000Z
- Updated: 2025-09-04T15:37:52.000Z
- Description: In this phase 2b, multicenter, randomized, double-blind, placebo-controlled study of 4 dose levels of MM120 (a form of LSD) that included 198 adults with generalized anxiety disorder 4 was statistically significant.
- Author: Michael DeMarco, PhD
- Tags: lsd, anxiety, generalized anxiety disorder, psychedelics, psychedelic therapy, psychedelic research, research, lsd research, mm120, mindmed

[![](https://storage.ghost.io/c/61/a8/61a8484e-df24-47fb-903c-d012ff10c983/content/images/2025/09/image-2.png)](https://jamanetwork.com/journals/jama/article-abstract/2838505)

2025: These findings support the selection of 100 µg of MM120 as the optimal dose for pivotal clinical trials evaluating treatment for participants with moderate to severe generalized anxiety disorder.